Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer
Condition(s):Breast Cancer and Ovarian CancerLast Updated:July 23, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Breast Cancer and Ovarian CancerLast Updated:July 23, 2021Completed
Condition(s):Endometrial Clear Cell Adenocarcinoma; Endometrial Mixed Adenocarcinoma; Endometrial Serous Adenocarcinoma; Grade 3 Endometrial Endometrioid Adenocarcinoma; Malignant Mixed Mesodermal (Mullerian) TumorLast Updated:November 7, 2023Active, not recruiting
Condition(s):Squamous Cell Carcinoma; Urinary Tract CancerLast Updated:October 3, 2022Recruiting
Condition(s):Prostate CancerLast Updated:October 31, 2018Completed
Condition(s):Ovarian CancerLast Updated:March 8, 2024Recruiting
Condition(s):Ovarian CancerLast Updated:March 18, 2015Withdrawn
Condition(s):Metabolic Syndrome; Testicular Cancer; Leydig Cell Failure in AdultLast Updated:March 6, 2020Completed
Condition(s):Kidney Cancer; Liver CancerLast Updated:February 6, 2020Completed
Condition(s):Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Urinary TractLast Updated:November 25, 2020Completed
Condition(s):Prostatic NeoplasmsLast Updated:July 14, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.